Baseline clinical features but not TLL1 variants predicts HCC onset in Caucasian compensated HBV cirrhotics treated by Entecavir or Tenofovir for 8 years
Digestive and Liver Disease(2018)
Abstract
Background and aims: As HCC remains the leading complication in HBV compensated cirrhotics long-term TDF/ETV treated, we aimed to define baseline predictors of HCC, including the tolloid like 1 gene (TLL1) rs17047200 polymorphism which predicts HCC in HCV patients cured by IFN therapy.
MoreTranslated text
Key words
hbv cirrhotics,hcc,tll1 variants,entecavir,baseline clinical features
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined